NCT02852551View on ClinicalTrials.gov

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
DRUG

PAT-1251

DRUG

Placebo

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd., Leeds

Sponsors

Lead Sponsor

PharmAkea, Inc.
All Listed Sponsors
lead

PharmAkea, Inc.

INDUSTRY